๐ฐ All Variants Reported News
All Variants Reported News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from All Variants Reported. Real-time updates on events, politics, business and more.
December 25, 2021
EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities - read this article along with other careers information, tips and advice on BioSpace
December 21, 2021
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination...
December 16, 2021
16.12.2021 - AstraZenecaโs EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained neutralizing activity against the Omicron SARS-CoV-2 variant (B.1.1.529), according to new preclinical ...
December 9, 2021
09.12.2021 - AstraZenecas EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses ...
October 11, 2021
Investegate announcements from AstraZeneca PLC, AZD7442 PhIII trial positive in COVID outpatients
October 11, 2021
Positive high-level results from the TACKLE Phase III COVID-19 treatment trial showed AstraZeneca's AZD7442, a long acting antibody (LAAB) combination,...